Telehealth practice recommendations for diabetic retinopathy

被引:45
作者
Linkous, JD
Bakalar, R
Darkins, A
Poropatich, RK
Cavallerano, J
Lawrence, MG
Li, HK
Tennant, M
Bursell, S
Cavallerano, J
Horton, M
Bakalar, R
Cavallerano, J
Lawrence, MG
Zimmer-Galler, I
Bauman, W
Bursell, S
Gardner, WK
Horton, M
Hildebrand, L
Federman, J
Carnahan, L
Kuzmak, P
Peters, JM
Darkins, A
Ahmed, J
Aiello, LM
Aiello, LP
Buck, G
Chen, YL
Cunningham, D
Goodall, E
Huang, E
Hubbard, L
Janczewski, M
Lewis, JWL
Matsuzaki, H
McVeigh, FL
Motzno, J
Parker-Taillon, D
Read, R
Soliz, P
Szirth, B
Vigersky, RA
Ward, T
Diver, C
机构
[1] Amer Telemed Assoc, Washington, DC 20036 USA
[2] Univ Texas, Med Branch, Dept Ophthalmol & Visual Sci, Galveston, TX 77555 USA
来源
TELEMEDICINE JOURNAL AND E-HEALTH | 2004年 / 10卷 / 04期
关键词
D O I
10.1089/tmj.2004.10.469
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Telehealth holds the promise of increased adherence to evidenced- based medicine and improved consistency of care. Goals for an ocular telehealth program include preserving vision, reducing vision loss, and providing better access to medicine. Establishing recommendations for an ocular telehealth program may improve clinical outcomes and promote informed and reasonable patient expectations. This document addresses current diabetic retinopathy telehealth clinical and administrative issues and provides recommendations for designing and implementing a diabetic retinopathy ocular telehealth care program. The recommendations also form the basis for evaluating diabetic retinopathy telehealth techniques and technologies. Recommendations in this document are based on careful reviews of current evidence, medical literature and clinical practice. They do not, however, replace sound medical judgment or traditional clinical decision- making. " Telehealth Practice Recommendations for Diabetic Retinopathy" will be annually reviewed and updated to reflect evolving technologies and clinical guidelines.
引用
收藏
页码:469 / 482
页数:14
相关论文
共 57 条
[51]  
Stearne MR, 1998, BMJ-BRIT MED J, V317, P703
[52]   Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) [J].
Turner, RC ;
Holman, RR ;
Cull, CA ;
Stratton, IM ;
Matthews, DR ;
Frighi, V ;
Manley, SE ;
Neil, A ;
McElroy, K ;
Wright, D ;
Kohner, E ;
Fox, C ;
Hadden, D ;
Mehta, Z ;
Smith, A ;
Nugent, Z ;
Peto, R ;
Adlel, AI ;
Mann, JI ;
Bassett, PA ;
Oakes, SF ;
Dornan, TL ;
Aldington, S ;
Lipinski, H ;
Collum, R ;
Harrison, K ;
MacIntyre, C ;
Skinner, S ;
Mortemore, A ;
Nelson, D ;
Cockley, S ;
Levien, S ;
Bodsworth, L ;
Willox, R ;
Biggs, T ;
Dove, S ;
Beattie, E ;
Gradwell, M ;
Staples, S ;
Lam, R ;
Taylor, F ;
Leung, L ;
Carter, RD ;
Brownlee, SM ;
Fisher, KE ;
Islam, K ;
Jelfs, R ;
Williams, PA ;
Williams, FA ;
Sutton, PJ .
LANCET, 1998, 352 (9131) :837-853
[53]  
*VA, 2003, VHA INF CONS CLIN TR
[54]  
*WHO, 2004, DIAB EST PROJ
[55]   Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales [J].
Wilkinson, CP ;
Ferris, FL ;
Klein, RE ;
Lee, PP ;
Agardh, CD ;
Davis, M ;
Dills, D ;
Kampik, A ;
Pararajasegaram, R ;
Verdaguer, JT .
OPHTHALMOLOGY, 2003, 110 (09) :1677-1682
[56]   OPHTHALMOLOGIC CARE FOR PERSONS WITH DIABETES [J].
WITKIN, SR ;
KLEIN, R .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1984, 251 (19) :2534-2537
[57]  
Zeimer R, 2002, INVEST OPHTH VIS SCI, V43, P1581